Manic/hypomanic symptoms induced by atypical antipsychotics: A review of the reported cases

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 30, Issue 4, 2006, Pages 549-564

  Michalopoulou, Panayiota G ^a   Lykouras, Lefteris ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Atypical antipsychotics; Bipolar disorder; Hypomanic manic symptoms; Schizophrenia

Indexed keywords

ALPRAZOLAM; AMISULPRIDE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZATROPINE; BIPERIDEN; CHLORPROMAZINE; DIAZEPAM; FLUOXETINE; FLUPHENAZINE; GABAPENTIN; HALOPERIDOL; LITHIUM; LOXAPINE; NITRAZEPAM; OLANZAPINE; OXCARBAZEPINE; PAROXETINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; SERTRALINE; TEMAZEPAM; THIORIDAZINE; TRIFLUOPERAZINE; TRIHEXYPHENIDYL; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; ZIPRASIDONE; ZUCLOPENTHIXOL;

CLINICAL PRACTICE; DEMOGRAPHY; DRUG DOSE REDUCTION; HUMAN; HYPOMANIA; MANIA; MENTAL DISEASE; MONOTHERAPY; OUTCOME ASSESSMENT; PATHOGENESIS; PSYCHIATRIC DIAGNOSIS; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SYMPTOM; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 33748679331     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2005.11.026     Document Type: Review

References (61)

1. Andreasen N.C. Negative symptoms in schizophrenia. Definition and reliability. Arch Gen Psychiatry 39 (1982) 784-788
2. Atmaca M., Kuloglu M., Buyukbayram A., and Tezcan E. Quetiapine-associated and dose-related hypomania in a woman with schizophrenia. Eur Psychiatry 17 (2002) 292-293
3. Aubry J.-M., Simon A.E., and Bertschy G. Possible induction of mania and hypomania by olanzapine or risperidone: a critical review of reported cases. J Clin Psychiatry 61 (2000) 649-655
4. Baldassano C.F., Ballas C., Datto S.M., Kim D., Littman L., O'Reardon J., et al. Ziprasidone-associated mania: a case series and review of the mechanism. Bipolar Disord 5 (2003) 72-75
5. Barbee J.G., Conrad E.J., and Jamhour N.J. The effectiveness of olanzapine, risperidone, quetiapine and ziprasidone as augmentation agents in treatment-resistant major depressive disorder. J Clin Psychiatry 65 (2004) 975-981
6. Barkin J.S., and Pais V.M. Induction of mania by risperidone resistant to mood stabilizers (letter). J Clin Psychopharmacol 17 (1997) 57-58
7. Benazzi F. Olanzapine-induced psychotic mania in bipolar schizo-affective disorder. Eur Psychiatry 14 (1999) 410-411
8. Benazzi F. Quetiapine-associated hypomania in a woman with schizoaffective disorder (letter). Can J Psychiatry 46 (2001) 182-183
9. Benazzi F., and Rossi E. Mania induced by olanzapine. Hum Psychopharmacol Clin Exp 13 (1998) 585-586
10. Bertolino A., Caforio G., Blasi G., De Candia M., Lattore V., Petruzzella V., et al. Interaction of COMT Val 108/158 Met genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. Am J Psychiatry 161 (2004) 1798-1805
11. Biancosino B., Marmai L., Facchi A., Rossi E., and Grassi L. Quetiapine may induce mania: a case report (letter). Can J Psychiatry 48 (2003) 349-350
12. Bressan A.R., Erlandson K., Jones M.H., Mullingan R., Flanagan J.R., Ell J.P., et al. Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? An in vivo quantitative [123I] Epidepride SPET study of amisulpride-treated patients. Am J Psychiatry 160 (2003) 1413-1420
13. Bymaster F., Perry K.W., Nelson D.L., Wong D.T., Rasmussen K., Moore N.A., et al. Olanzapine: a basic science update. Br J Psychiatry Suppl. 37 (1999) 36-40
14. Curran M.P., and Perry C.M. Spotlight on amisulpride in schizophrenia. CNS Drugs 16 (2002) 207-211
15. Davis R., and Risch S.C. Ziprasidone induction of hypomania in depression? (Letter). Am J Psychiatry 159 (2002) 673-674
16. Diaz S.F. Mania associated with risperidone use (letter). J Clin Psychiatry 57 (1996) 41-42
17. Dwight M.M., Keck P.E., Stanton S.P., Strakowski S.M., and McElroy S.L. Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder (letter). Lancet 344 (1994) 554-555
18. Fahy S., and Fahy T.J. Induction of manic symptoms by novel antipsychotics (letter). Br J Psychiatry 176 (2000) 597
19. Fitz-Gerald M.J., Pinkofsky H.B., Brannon G., Dandridge E., and Calhoun A. Olanzapine-induced mania (letter). Am J Psychiatry 156 (1999) 1114
20. Ghaemi S.N., Hsu J.D., Soldani F., and Goodwin K.F. Antidepressants in bipolar disorder: the case for caution. Bipolar Disord 5 (2003) 421-433
21. Güzelcan Y., De Haan L., and Scholte W.F. Risperidone may induce mania. Psychopharmacology 162 (2002) 85-86
22. Henry C., and Demotes-Mainard J. Olanzapine-induced mania in bipolar disorders. J Psychiatry Neurosci 27 (2002) 200-201
23. Ichikawa J., Ishii H., Bonaccorso S., Fowler W.L., O'Loughlin I.A., and Meltzer H.Y. 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. J Neurochem 76 (2001) 1521-1531
24. Ishak W.W., Rapaport M.H., and Gotto J.G. The effectiveness of atypical antipsychotics medications in depressive disorders. Curr Psychiatry Rep 6 (2004) 422-424
25. John V., Rapp M., and Pies R. Aggression, agitation and mania with olanzapine (letter). Can J Psychiatry 43 (1998) 1054
26. Kapur S., and Seeman Ph. Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics? A new hypothesis. Am J Psychiatry 158 (2001) 360-369
27. Koek R.J., and Kessler C.C. Probable induction of mania by risperidone (letter). J Clin Psychiatry 57 (1996) 174-175
28. Lane H., Lin Y., and Chang W. Mania induced by risperidone: dose-related?. J Clin Psychiatry 59 (1998) 85-86
29. Larson M.F., and Hauser A. Possible ziprasidone-induced mania (letter). J Am Acad Child Adolesc Psychiatry 42 (2003) 1012
30. Lindenmayer J.-P., and Klebanov R. Olanzapine-induced manic like syndrome (letter). J Clin Psychiatry 59 (1998) 318-319
31. London A.J. Mania associated with olanzapine (letter). J Am Acad Child Adolesc Psychiatry 37 (1998) 135-136
32. 2A in mood changes induced by atypical antipsychotics (letter). J Clin Psychiatry 63 (2002) 1185-1186
33. Lykouras L., Gournellis R., and Angelopoulos E. Manic symptoms induced by olanzapine. Eur Neuropsychopharmacol 11 (2001) 97-98
34. Lykouras L., Oulis P., and Hatzimanolis J. Manic symptoms associated with quetiapine treatment. Eur Neuropsychopharmacol 13 (2003) 135-136
35. Lykouras L., Alevizos V., Michalopoulou P., and Rabavilas A. Obsessive-compulsive symptoms induced by atypical antipsychotics. A review of the reported cases. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 333-346
36. Masan P.S. Atypical antipsychotics in the treatment of affective symptoms: a review. Ann Clin Psychiatry 16 (2004) 3-13
37. Meltzer H.Y., Matsurbara S., and Lee J.C. The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs. Psychopharmacol Bull 25 (1989) 390-392
38. Mensink G.J., and Sloof C.J. Novel antipsychotics in bipolar and schizoaffective mania. Acta Psychiatr Scand 109 (2004) 405-419
39. Murphy B.P. Amisulpride-induced mania in a patient with schizophrenia. Br J Psychiatry 183 (2003) 172
40. Naber D., and Lambert M. Aripipprazole: a new atypical antipsychotic with a different pharmacological mechanism. Prog Neuropsychopharmacol Biol Psychiatry 28 (2004) 1213-1219
41. Narayan G., and Puranik A. Olanzapine-induced mania. Int J Psychiatry Clin Pract 4 (2000) 333-334
42. Nemeroff C.B., Kinkead B., and Goldstein I. Quetiapine: preclinical studies, pharmacokinetics, drug interactions and dosing. J Clin Psychiatry 63 Suppl. 13 (2002) S5-S11
43. Nolan B.P., and Schulte Jr. J.J. Mania associated with initiation of ziprasidone. J Clin Psychiatry 64 (2003) 336
44. Pacchiarotti I., Manfredi G., Kotzalidis G.D., Girardi P., and Tatarelli R. Quetiapine-induced mania (letter). Aust N Z J Psychiatry 37 (2003) 626
45. Pozo P., and Alcantara A.G. Mania-like syndrome in a patient with chronic schizophrenia during olanzapine treatment (letter). J Psychiatry Neurosci 23 (1998) 309-310
46. Privitera M.R., and Maharaj K. Mania from dose-related ziprasidone augmentation of an SSRI (letter). J Clin Psychiatry 64 (2003) 1393-1394
47. Reeves R.R., McBride W.A., and Brannon G.E. Olanzapine-induced mania. J Am Osteopath Assoc 98 (1998) 549-550
48. 2 and 5-HT2 receptor effects of antipsychotics: bridging basic and clinical findings using PET. J Clin Psychiatry 60 Suppl. 10 (1999) S15-S19
49. Richelson E. Receptor pharmacology of neuroleptics: relation to clinical effects. J Clin Psychiatry 60 Suppl. 10 (1999) S5-S14
50. Robertson M.M., and Trimble M.R. Major tranquillisers used as antidepressants. J Affect Disord 4 (1982) 173-193
51. Rothschild A.J., Williamson D.J., and Tohen M.F. A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features. J Clin Psychopharmacol 24 (2004) 365-373
52. Schatzberg A.F., and Rothschild A.J. Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV?. Am J Psychiatry 149 (1992) 733-745
53. Schmidt A.W., Lebel A.L., Howard Jr. H.R., and Zorn S.H. Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile. Eur J Pharmacol 425 (2001) 197-201
54. Schnierow B.J., and Graeber D.A. Manic symptoms associated with initiation of risperidone (letter). Am J Psychiatry 153 (1996) 1235-1236
55. Simon A.E., Aubry J.M., Malky L., and Bertschy G. Hypomania-like syndrome induced by olanzapine. Int Clin Psychopharmacol 14 (1999) 377-378
56. Tomlinson C.W. Risperidone and mania (letter). Am J Psychiatry 153 (1996) 132-133
57. Yatham L.N. Acute and maintenance treatment of bipolar mania: the role of atypical antipsychotics. Bipolar Disord 5 Suppl. 2 (2003) S7-S19
58. Yazici O., Kora K., Polat A., and Sayla M. Controlled lithium discontinuation in bipolar patients with good response to long-term lithium prophylaxis. J Affect Disord 80 (2004) 269-271
59. Young R.C., Biggs J.T., Ziegler V.E., and Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133 (1978) 429-435
60. Zhang W., Perry K.W., Wong D.T., Potts B.D., Jingqi B., Tollefson G.D., et al. Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex. Neuropsychopharmacology 23 (2000) 250-262
61. Zolezzi M., and Badr M.G. Risperidone-induced mania (letter). Ann Pharmacother 33 (1999) 380-381